Back
Cassava Sciences Vs. Adverum Biotechnologies Industry Stock Comparison
Sell
20
SAVA
Cassava Sciences
Last Price:
3.83
Seasonality Move:
36.76%
Sell
38
ADVM
Adverum Biotechnologies
Last Price:
6.16
Seasonality Move:
22.26%
Sell
20
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $4.30. The Score for SAVA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Adverum Biotechnologies (ADVM)
is a Sell
Is Adverum Biotechnologies a Buy, Sell or Hold?
- The current Adverum Biotechnologies [ADVM] share price is $6.15. The Score for ADVM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $4.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing slight buying pressure.
ADVM Stock Price Chart
What is Adverum Biotechnologies's stock price today?
-
The Adverum Biotechnologies share price today is $6.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.61 | Sell |
| Relative Strength Index (14 RSI): | 23.57 | Sell |
| Chaikin Money Flow: | 3252101 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.23 - 30.51) | Sell |
| Bollinger Bands (100): | (17.97 - 31.33) | Sell |
ADVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 33.55 | Sell |
| Chaikin Money Flow: | -115978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.64 - 8.1) | Sell |
| Bollinger Bands (100): | (6.7 - 8) | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.75 | Sell |
| 20-day SMA: | 25.49 | Sell |
| 50-day SMA: | 27.05 | Sell |
| 200-day SMA: | 22.83 | Sell |
| 8-day EMA: | 22.44 | Sell |
| 20-day EMA: | 24.97 | Sell |
| 50-day EMA: | 25.95 | Sell |
| 200-day EMA: | 24.04 | Sell |
ADVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.42 | Sell |
| 20-day SMA: | 7.2 | Sell |
| 50-day SMA: | 7.38 | Sell |
| 200-day SMA: | 9.77 | Sell |
| 8-day EMA: | 6.43 | Sell |
| 20-day EMA: | 6.97 | Sell |
| 50-day EMA: | 7.28 | Sell |
| 200-day EMA: | 8.75 | Sell |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.
Cassava Sciences Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adverum Biotechnologies Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||